Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Adv Skin Wound Care ; 20(6): 331-45, 2007 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-17538259

RESUMO

OBJECTIVES: To evaluate cytotoxicity and bactericidal effects of chloramine-T. METHODS: In vitro study of various concentrations and exposure times to preparations containing human fibroblasts or 1.5 x 10 colony forming units per milliliter (CFU/mL) of 3 gram-positive bacteria-Staphylococcus aureus, methicillin-resistant S aureus, and vancomycin-resistant Enterococcus faecalis-and 2 gram-negative bacteria-Escherichia coli and Pseudomonas aeruginosa-with and without fetal bovine serum present. MAIN OUTCOME MEASURES: Percentage reduction of bacterial growth and percentage of viable fibroblasts 48 hours after exposure. RESULTS: All gram-positive growth was reduced by 95% to 100%, regardless of dose, with or without serum. E coli (gram-negative; with/without serum) was reduced 94% to 100% at antiseptic concentrations of 300 and 400 ppm. At 200 ppm, E coli growth was fully inhibited without serum present and by 50% with serum. P aeruginosa (gram-negative) was not significantly affected under any conditions. At 100 and 200 ppm, cell viability remained greater than 90% under all experimental conditions. A 300-ppm, 3-minute exposure to chloramine-T resulted in cell viability of up to 70%, with longer exposures producing lower viabilities. Serum did not affect cell viability in any condition. CONCLUSIONS: In vitro, chloramine-T at 200 ppm for 5 to 20 minutes was effective against 3 virulent gram-positive bacteria without fibroblast damage. At 300 ppm and 3 and 5 minutes, 30% of fibroblasts were damaged and 95% to 100 % of E coli were inhibited, respectively.


Assuntos
Anti-Infecciosos Locais/uso terapêutico , Infecções Bacterianas/tratamento farmacológico , Cloraminas/uso terapêutico , Fibroblastos/efeitos dos fármacos , Compostos de Tosil/uso terapêutico , Infecção dos Ferimentos/tratamento farmacológico , Anti-Infecciosos Locais/química , Anti-Infecciosos Locais/farmacologia , Infecções Bacterianas/microbiologia , Técnicas de Cultura de Células , Sobrevivência Celular/efeitos dos fármacos , Cloraminas/química , Cloraminas/farmacologia , Contagem de Colônia Microbiana , Avaliação Pré-Clínica de Medicamentos , Enterococcus faecalis , Infecções por Escherichia coli/tratamento farmacológico , Fibroblastos/ultraestrutura , Infecções por Bactérias Gram-Positivas/tratamento farmacológico , Humanos , Resistência a Meticilina , Testes de Sensibilidade Microbiana , Infecções por Pseudomonas/tratamento farmacológico , Pseudomonas aeruginosa , Infecções Estafilocócicas/tratamento farmacológico , Staphylococcus aureus , Fatores de Tempo , Compostos de Tosil/química , Compostos de Tosil/farmacologia , Resistência a Vancomicina , Infecção dos Ferimentos/microbiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...